Clinical Trial Update: A Study of Sequential Therapy of Camrelizumab Combined With Chemotherapy（Irinotecan Plus Platinum）and With Apatinib in Participants With Untreated Advanced Small Cell Lung Cancer（SCLC） [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sequential camrelizumab with chemotherapy (irinotecan + platinum) followed by apatinib in untreated advanced small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Carcinoma

Drugs mentioned

• Apatinib (apatinib)
• Camrelizumab (camrelizumab)
• Irinotecan (Irinotecan)
• Platinum-based chemotherapy (platinum-based chemotherapy)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Small Cell Lung Carcinoma | Phase 2 | Status: UNKNOWN